Overall risk of VTE among outpatients with COVID-19 low, but higher in the first 30 days after diagnosis
Overall risk of VTE among outpatients with COVID-19 is low, but higher in the first 30 days after diagnosis suggests a new study published in the JAMA Network Open
Patients hospitalized with COVID-19 have higher rates of venous thromboembolism (VTE), but the risk and predictors of VTE among individuals with less severe COVID-19 managed in outpatient settings are less well understood.
A study was done to assess the risk of VTE among outpatients with COVID-19 and identify independent predictors of VTE.
A retrospective cohort study was conducted at 2 integrated health care delivery systems in Northern and Southern California. Data for this study were obtained from the Kaiser Permanente Virtual Data Warehouse and electronic health records. Participants included nonhospitalized adults aged 18 years or older with COVID-19 diagnosed between January 1, 2020, and January 31, 2021, with follow-up through February 28, 2021. Patient demographic and clinical characteristics identified from integrated electronic health records. The primary outcome was the rate per 100 person-years of diagnosed VTE, which was identified using an algorithm based on encounter diagnosis codes and natural language processing. Multivariable regression using a Fine-Gray subdistribution hazard model was used to identify variables independently associated with VTE risk. Multiple imputation was used to address missing data.
Results
A total of 398 530 outpatients with COVID-19 were identified.
The mean (SD) age was 43.8 (15.8) years, 53.7% were women, and 54.3% were of self-reported Hispanic ethnicity.
There were 292 (0.1%) VTE events identified over the follow-up period, for an overall rate of 0.26 per 100 person-years.
The sharpest increase in VTE risk was observed during the first 30 days after COVID-19 diagnosis
In multivariable models, the following variables were associated with a higher risk for VTE in the setting of nonhospitalized COVID-19: age 55 to 64 years, 65 to 74 years, 75 to 84 years, greater than or equal to 85 years, male gender, prior VTE, thrombophilia, inflammatory bowel disease, body mass index 30.0-39.9, and body mass index greater than or equal to 40.0
In this cohort study of outpatients with COVID-19, the absolute risk of VTE was low. Several patient-level factors were associated with higher VTE risk; these findings may help identify subsets of patients with COVID-19 who may benefit from more intensive surveillance or VTE preventive strategies.
Reference:
Fang MC, Reynolds K, Tabada GH, et al. Assessment of the Risk of Venous Thromboembolism in Nonhospitalized Patients With COVID-19. JAMA Netw Open. 2023;6(3):e232338. doi:10.1001/jamanetworkopen.2023.2338
